¶
authors: Feng et al.
title: BRIP1 in neuronal survival (2022)
year: 2022
doi: 10.1186/s13024-022-00527-x
zhang2021:
authors: Zhang et al.
title: DNA repair defects in AD (2021)
year: 2021
doi: 10.1093/brain/awab078
sarkar2020:
authors: Sarkar et al.
title: E3 ligases in neurodegeneration (2020)
year: 2020
doi: 10.1016/j.neurobiolaging.2020.02.016
wang2019:
authors: Wang et al.
title: DNA repair and aging (2019)
year: 2019
doi: 10.1016/j.arr.2019.03.004
kim2021:
title: Kim and Lee, BRIP1 mutations and disease (2021)
year: 2021
doi: 10.1093/jmg/jkab012
sanjana2012:
authors: Sanjana et al.
title: DNA damage and neuronal death (2012)
year: 2012
pmid: '22860478'
thadani2018:
authors: Thadani et al.
title: DNA repair in neurons (2018)
year: 2018
pmid: '29799499'
mcKinnon2017:
authors: McKinnon et al.
title: DNA repair and nervous system development (2017)
year: 2017
pmid: '28437039'
herbert2013:
authors: Herbert et al.
title: Base excision repair in brain (2013)
year: 2013
pmid: '23833785'
bohr2002:
authors: Bohr et al.
title: DNA repair and aging in the brain (2002)
year: 2002
pmid: '12417153'
nouspikel1997:
authors: Nouspikel et al.
title: DNA repair in postmitotic neurons (1997)
year: 1997
pmid: '9056608'
kruman2004:
authors: Kruman et al.
title: DNA damage and neuronal apoptosis (2004)
year: 2004
pmid: '14749477'
englander2012:
authors: Englander et al.
title: Chromatin remodeling in DNA repair (2012)
year: 2012
pmid: '22561864'
[^1]
[^2]
[^3]
[^4]
[^5]
| BRIP1 - BRCA1 interacting protein C-terminal helicase 1 |
|---|
| Gene Symbol | BRIP1 |
| Full Name | BRCA1 interacting protein C-terminal helicase 1 |
| Chromosomal Location | 17q23.2 |
| NCBI Gene ID | [83990](https://www.ncbi.nlm.nih.gov/gene/83990) |
| OMIM | [605882](https://www.omim.org/entry/605882) |
| Ensembl ID | [ENSG00000136492](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000136492) |
| UniProt ID | [Q9UQM7](https://www.uniprot.org/uniprot/Q9UQM7) |
| Associated Diseases | Fanconi Anemia, Breast Cancer, Ovarian Cancer, Neurodegeneration |
BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1) is a DNA helicase that plays essential roles in DNA damage response, repair, and genome stability. Originally identified as an interacting partner of BRCA1, BRIP1 participates in multiple DNA repair pathways critical for neuronal survival. Mutations in BRIP1 cause Fanconi anemia subtype J (FA-J) and predispose to breast and ovarian cancer.
BRIP1 is a 1,249 amino acid protein belonging to the RecQ family of DNA helicases. It possesses both helicase and ATPase activity, enabling it to unwind DNA structures during repair processes. The enzyme is ubiquitously expressed with particularly high levels in proliferating cells and neurons, where DNA integrity is paramount for function and survival.
BRIP1 participates in multiple DNA repair mechanisms:
-
Homologous Recombination (HR): BRIP1 collaborates with BRCA1 to resolve DNA double-strand breaks through homologous recombination. The helicase activity helps process DNA ends for RAD51-mediated strand invasion [1].
-
Fanconi Anemia Pathway: BRIP1 (also known as FANCJ) is essential for the Fanconi anemia DNA repair pathway, which specifically repairs interstrand DNA crosslinks [2].
-
Checkpoint Activation: BRIP1 contributes to ATM/ATR-mediated cell cycle checkpoint activation following DNA damage.
-
Transcription-Coupled Repair: The helicase participates in transcription-coupled nucleotide excision repair, removing lesions that block transcription.
BRIP1 directly interacts with BRCA1 through its C-terminal BRCT domain:
- Complex Formation: BRIP1-BRIP1 and BRIP1-BRCA1 complexes form at damage sites.
- Signaling: The interaction facilitates recruitment of downstream repair proteins.
- Coordination: BRIP1's helicase activity is regulated by BRCA1-mediated phosphorylation.
Beyond direct DNA repair, BRIP1 influences chromatin structure:
- Histone Modifications: BRIP1 affects histone H2AX phosphorylation and γH2AX spread.
- Chromatin Accessibility: The helicase promotes chromatin opening for repair machinery access.
- Epigenetic Regulation: Altered BRIP1 activity can affect gene expression patterns.
BRIP1 contains several functional domains:
- DEAD Box Helicase Core: The central region contains conserved motifs for ATP binding and hydrolysis (motifs I, II, III, VI) and helicase activity (motifs Ia, Ib, IV-V).
- BRCT Domain: The C-terminal BRCT (BRCA1 C-terminal) domain mediates protein-protein interactions with phosphorylated targets.
- DNA Binding Domain: Multiple DNA-binding regions facilitate substrate recognition.
The protein functions as both a monomer and in complexes with BRCA1 and other repair proteins.
- DNA Damage Accumulation: Neuronal DNA damage accumulates in AD brains; impaired BRIP1 function may exacerbate this [3].
- Genomic Instability: Reduced BRIP1 activity contributes to genomic instability in neurons.
- Amyloid Toxicity: DNA damage responses are activated in response to amyloid-beta; BRIP1 may modulate this response.
- Tau Pathology: DNA repair deficits may interact with tau pathology to accelerate neurodegeneration.
- Oxidative DNA Damage: BRIP1 helps repair oxidative DNA lesions common in PD brains.
- Mitochondrial DNA Repair: The enzyme may participate in mitochondrial DNA repair pathways.
- α-Synuclein Connection: DNA damage responses may be altered in neurons with α-synuclein aggregation.
- Transcriptional Dysregulation: BRIP1 dysfunction may contribute to transcriptional abnormalities in HD.
- DNA Repair Impairment: Multiple DNA repair pathways are compromised in HD; BRIP1-mediated repair is affected.
- Aging Phenotype: HD exhibits features of accelerated aging, including DNA damage accumulation.
- Motor Neuron Vulnerability: Motor neurons exhibit particular sensitivity to DNA damage due to their high metabolic activity.
- TDP-43 Pathology: DNA repair dysfunction may interact with TDP-43 aggregation in ALS.
- Oxidative Stress: BRIP1's role in repairing oxidative DNA damage is relevant to ALS pathogenesis.
BRIP1 mutations cause Fanconi anemia subtype J (FA-J), characterized by:
- Developmental Abnormalities: Growth retardation, skeletal anomalies
- Bone Marrow Failure: Progressive pancytopenia
- Cancer Predisposition: Dramatically increased risk of leukemia and solid tumors
- Neurological Features: Some patients exhibit neurodegeneration
FA-J cells show hypersensitivity to interstrand DNA crosslinking agents and impaired homologous recombination.
BRIP1 possesses ATP-dependent DNA helicase activity enabling it to unwind double-stranded DNA:
- Strand Unwinding: The helicase separates DNA strands ahead of repair machinery
- Fork Regression: Can regress stalled replication forks to facilitate repair
- D-loop Formation: Facilitates strand invasion during homologous recombination
- G-quadruplex Resolution: Resolves G-quadruplex structures that can block transcription
BRIP1 interacts with multiple DNA repair proteins:
- BRCA1: Direct interaction through BRIP1's BRCT domain
- FANCD2: Part of the Fanconi anemia core complex
- RAD51: Facilitates strand invasion during HR
- ATM/ATR: Coordinate checkpoint activation
BRIP1 activity is tightly regulated:
- Phosphorylation: BRCA1-mediated phosphorylation activates BRIP1 helicase activity
- Cell Cycle Control: Activity peaks in S/G2 phases
- Post-Translational Modifications: Ubiquitination affects protein stability
¶ Expression and Localization
BRIP1 is expressed in the brain with regional variation:
- Neuronal Expression: High in pyramidal neurons of cortex and hippocampus
- Glial Expression: Present in astrocytes and oligodendrocytes
- Developmental Regulation: Expression peaks during neurogenesis
- Nucleus: Primary nuclear localization
- Chromatin: Associated with chromatin during DNA repair
- Nucleolus: Some nucleolar localization reported
¶ Aging and DNA Repair
BRIP1 function declines with age, contributing to neurodegeneration:
- Expression Decline: BRIP1 expression decreases in aging brain
- Activity Reduction: Helicase activity diminishes with age
- Repair Backlog: Accumulated DNA damage exceeds repair capacity
- Mutational burden: Accumulated somatic mutations affect gene function
Restoring BRIP1 function could delay age-related neurodegeneration:
- Gene Therapy: Increase BRIP1 expression in vulnerable neurons
- Small Molecule Activators: Enhance helicase activity
- Combination Approaches: Target multiple DNA repair pathways
BRIP1 is evolutionarily conserved across species:
- Vertebrates: High conservation from fish to humans
- Invertebrates: Functional orthologs in Drosophila and C. elegans
- Yeast: RAD51 parallel functions exist
- Essential in all species: Non-redundant function
Key insights from model organisms:
- Drosophila: Homolog called mus309
- C. elegans: Homolog called him-6
- Zebrafish: Morpholino knockdown studies
- Mouse models: Knockout and transgenic lines
Notable differences across species:
- Protein length: Varies from 1000-1300 amino acids
- Domain architecture: Generally conserved
- Expression patterns: Broadly similar in neurons
- Functional redundancy: Varies by species
BRIP1 represents a therapeutic target for multiple applications:
- Cancer Therapy: PARP inhibitors are synthetically lethal in cells with BRIP1 deficiency.
- Neuroprotection: Enhancing BRIP1-mediated DNA repair could protect neurons.
- Combination Approaches: BRIP1 modulators may synergize with other DNA damage response therapies.
- Aging Interventions: Maintaining DNA repair capacity may delay neurodegeneration.
The study of Brip1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
¶ Summary and Key Takeaways
BRIP1 serves essential roles in neuronal DNA repair:
- DNA helicase activity: Unwinds DNA structures during repair
- BRCA1 interaction: Forms functional complexes for homologous recombination
- Fanconi anemia pathway: Essential for interstrand crosslink repair
- Neuronal genome maintenance: Preserves genomic integrity in postmitotic neurons
BRIP1 dysfunction contributes to:
- Neurodegeneration: Accumulated DNA damage in neurons
- Cancer predisposition: Loss of cell cycle control
- Aging: Declining repair capacity
- Developmental defects: When mutated
Targeting BRIP1 offers multiple opportunities:
- Neuroprotection: Enhancing DNA repair capacity
- Cancer therapy: Synthetic lethality with PARP inhibitors
- Aging interventions: Maintaining genomic integrity
- Combination approaches: Multi-target strategies
BRIP1 coordinates with multiple DNA repair systems:
flowchart TD
A["BRIP1<br/>Activity"] --> B["Homologous<br/>Recombination"]
A --> C["Fanconi<br/>Anemia Pathway"]
A --> D["Base Excision<br/>Repair"]
A --> E["Nucleotide Excision<br/>Repair"]
B --> F["Double-strand<br/>Break Repair"]
C --> G["Crosslink<br/>Repair"]
D --> H["Base Damage<br/>Repair"]
E --> I["Bulky Lesion<br/>Repair"]
F --> J["Genomic<br/>Integrity"]
G --> J
H --> J
I --> J
style A fill:#c8e6c9,stroke:#333
style J fill:#e1f5fe,stroke:#333
BRIP1 interacts with cell signaling pathways:
- Cell cycle control: ATM/ATR checkpoint activation
- Apoptosis pathways: Balance between repair and cell death
- Transcription networks: Coupling to gene expression
- Metabolic pathways: Energy status affects repair